Le Min

3.7k total citations · 2 hit papers
42 papers, 2.6k citations indexed

About

Le Min is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Le Min has authored 42 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 13 papers in Molecular Biology and 9 papers in Epidemiology. Recurrent topics in Le Min's work include Cancer Immunotherapy and Biomarkers (17 papers), Hypothalamic control of reproductive hormones (8 papers) and Neuroendocrine Tumor Research Advances (7 papers). Le Min is often cited by papers focused on Cancer Immunotherapy and Biomarkers (17 papers), Hypothalamic control of reproductive hormones (8 papers) and Neuroendocrine Tumor Research Advances (7 papers). Le Min collaborates with scholars based in United States, China and Canada. Le Min's co-authors include F. Stephen Hodi, Sara M. Tolaney, Romualdo Barroso‐Sousa, Ursula B. Kaiser, Ian E. Krop, William T. Barry, Ana C. Garrido-Castro, Anand Vaidya, Carolyn Black Becker and Lee‐Shing Chang and has published in prestigious journals such as Journal of Biological Chemistry, Annals of Internal Medicine and Endocrine Reviews.

In The Last Decade

Le Min

40 papers receiving 2.5k citations

Hit Papers

Incidence of Endocrine Dysfunction Following the Use of D... 2017 2026 2020 2023 2017 2018 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Le Min United States 23 1.8k 726 518 484 463 42 2.6k
Atsuko Kasajima Japan 27 870 0.5× 680 0.9× 362 0.7× 598 1.2× 94 0.2× 97 1.8k
Christian Fottner Germany 26 698 0.4× 655 0.9× 435 0.8× 305 0.6× 676 1.5× 65 1.9k
Cinzia Azzoni Italy 26 1.3k 0.7× 1.3k 1.7× 671 1.3× 433 0.9× 101 0.2× 88 2.3k
S.W.J. Lamberts Netherlands 28 1.1k 0.6× 1.7k 2.3× 962 1.9× 422 0.9× 957 2.1× 55 2.9k
Christopher M. Heaphy United States 31 965 0.6× 554 0.8× 355 0.7× 1.0k 2.1× 40 0.1× 99 2.9k
Terry C. Lairmore United States 32 1.2k 0.7× 1.6k 2.2× 819 1.6× 620 1.3× 1.7k 3.7× 81 4.0k
William G. Dilley United States 21 636 0.4× 810 1.1× 300 0.6× 461 1.0× 1.1k 2.4× 40 2.1k
Stefania Scarpino Italy 20 355 0.2× 143 0.2× 117 0.2× 373 0.8× 211 0.5× 50 1.4k
Casilda Balmaceda United States 26 846 0.5× 232 0.3× 719 1.4× 396 0.8× 40 0.1× 51 2.4k
Guia Vannucchi Italy 28 229 0.1× 166 0.2× 286 0.6× 288 0.6× 1.5k 3.3× 57 2.4k

Countries citing papers authored by Le Min

Since Specialization
Citations

This map shows the geographic impact of Le Min's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Le Min with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Le Min more than expected).

Fields of papers citing papers by Le Min

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Le Min. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Le Min. The network helps show where Le Min may publish in the future.

Co-authorship network of co-authors of Le Min

This figure shows the co-authorship network connecting the top 25 collaborators of Le Min. A scholar is included among the top collaborators of Le Min based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Le Min. Le Min is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chou, Sharon H., et al.. (2025). Incidence of Hypercalcemia and Vertebral Fractures Following Denosumab Withdrawal in Lung Cancer Patients: A Longitudinal Cohort Study. Journal of Bone Metabolism. 32(1). 38–48. 1 indexed citations
2.
Min, Le, Dido Franceschi, Alan S. Livingstone, et al.. (2025). Factors Driving Attrition from Neoadjuvant Therapy to Pancreatectomy in Localized Pancreatic Cancer. Annals of Surgical Oncology. 33(3). 2642–2652.
3.
Lin, Wei, Wei Wang, F. Stephen Hodi, & Le Min. (2024). Gaps in the management of adrenal insufficiency in melanoma survivors: a retrospective cohort study. EClinicalMedicine. 79. 102984–102984. 1 indexed citations
4.
Cheung, Yee-Ming Melody, et al.. (2022). Factors leading to alpelisib discontinuation in patients with hormone receptor positive, human epidermal growth factor receptor-2 negative breast cancer. Breast Cancer Research and Treatment. 192(2). 303–311. 9 indexed citations
5.
Hamid, Omid, Anthony M. Joshua, Antoni Ribas, et al.. (2020). 1139P Long-term safety profile of pembrolizumab monotherapy and relationship with clinical outcome: A pooled analysis of patients with advanced melanoma. Annals of Oncology. 31. S762–S763. 2 indexed citations
6.
Hodi, F. Stephen, Anita Giobbie‐Hurder, Xiaocheng Wang, et al.. (2019). The Impact of High-Dose Glucocorticoids on the Outcome of Immune-Checkpoint Inhibitor–Related Thyroid Disorders. Cancer Immunology Research. 7(7). 1214–1220. 49 indexed citations
7.
Girotra, Monica, Aaron R. Hansen, Azeez Farooki, et al.. (2018). The Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for Management. JNCI Cancer Spectrum. 2(3). pky021–pky021. 89 indexed citations
8.
Ruan, Xiongzhong, et al.. (2017). Targeting both sides of the GDF15-GFRAL-RET receptor complex: A new approach to achieve body weight homeostasis. Genes & Diseases. 4(4). 183–184. 6 indexed citations
9.
Angell, Trevor E., Le Min, Tad J. Wieczorek, & F. Stephen Hodi. (2017). Unique cytologic features of thyroiditis caused by immune checkpoint inhibitor therapy for malignant melanoma. Genes & Diseases. 5(1). 46–48. 43 indexed citations
11.
Min, Le, Scott J. Rodig, Andrew F. Walls, et al.. (2016). Gene expression profiling of anti-CTLA4-treated metastatic melanoma in patients with treatment-induced autoimmunity. Laboratory Investigation. 97(2). 207–216. 13 indexed citations
12.
Min, Le. (2016). Immune-related endocrine disorders in novel immune checkpoint inhibition therapy. Genes & Diseases. 3(4). 252–256. 16 indexed citations
13.
Trarbach, Ericka Barbosa, Le Min, Alexander A.L. Jorge, et al.. (2014). Role of gonadotropin-releasing hormone receptor mutations in patients with a wide spectrum of pubertal delay. Fertility and Sterility. 102(3). 838–846.e2. 32 indexed citations
14.
Min, Le, Kathleen A. Soltis, Shuyun Xu, et al.. (2013). Dynamic Kisspeptin Receptor Trafficking Modulates Kisspeptin-Mediated Calcium Signaling. Molecular Endocrinology. 28(1). 16–27. 34 indexed citations
15.
Vaidya, Anand, Shelley Hurwitz, Maria A. Yialamas, Le Min, & Rajesh Garg. (2012). Improving the Management of Diabetes in Hospitalized Patients: The Results of a Computer-Based House Staff Training Program. Diabetes Technology & Therapeutics. 14(7). 610–618. 13 indexed citations
16.
Min, Le, Anand Vaidya, & Carolyn Black Becker. (2011). Association of Ipilimumab Therapy for Advanced Melanoma with Secondary Adrenal Insufficiency: A Case Series. Endocrine Practice. 18(3). 351–355. 50 indexed citations
17.
Min, Le, Anand Vaidya, & Carolyn Black Becker. (2010). Thyroid autoimmunity and ophthalmopathy related to melanoma biological therapy. European Journal of Endocrinology. 164(2). 303–307. 140 indexed citations
18.
Min, Le, Colette Galet, & Mario Ascoli. (2002). The Association of Arrestin-3 with the Human Lutropin/Choriogonadotropin Receptor Depends Mostly on Receptor Activation Rather than on Receptor Phosphorylation. Journal of Biological Chemistry. 277(1). 702–710. 53 indexed citations
20.
Min, Le & Mario Ascoli. (2000). Effect of Activating and Inactivating Mutations on the Phosphorylation and Trafficking of the Human Lutropin/Choriogonadotropin Receptor. Molecular Endocrinology. 14(11). 1797–1810. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026